Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
Axogen Inc (NASDAQ: AXGN) closed the day trading at $9.29 down -2.52% from the previous closing price of $9.53. In other words, the price has decreased by -$2.52 from its previous closing price. On the day, 0.55 million shares were traded. AXGN stock price reached its highest trading level at $9.585 during the session, while it also had its lowest trading level at $9.215.
Ratios:
For a better understanding of AXGN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.07 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 355.55. For the most recent quarter (mrq), Quick Ratio is recorded 2.65 and its Current Ratio is at 4.28. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.63.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on March 17, 2025, initiated with a Buy rating and assigned the stock a target price of $30.
On July 01, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $13.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 09 ’25 when Weiler Kathy Johnson sold 4,073 shares for $10.61 per share. The transaction valued at 43,215 led to the insider holds 6,580 shares of the business.
Levine Alan M sold 4,073 shares of AXGN for $43,215 on Jun 09 ’25. The Director now owns 36,743 shares after completing the transaction at $10.61 per share. On Jun 09 ’25, another insider, Wendell Amy McBride, who serves as the Director of the company, sold 4,073 shares for $10.61 each. As a result, the insider received 43,215 and left with 93,826 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXGN now has a Market Capitalization of 423103744 and an Enterprise Value of 472036160. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.18 while its Price-to-Book (P/B) ratio in mrq is 4.01. Its current Enterprise Value per Revenue stands at 2.427 whereas that against EBITDA is 71.968.
Stock Price History:
The Beta on a monthly basis for AXGN is 1.06, which has changed by 0.3641703 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, AXGN has reached a high of $21.00, while it has fallen to a 52-week low of $6.59. The 50-Day Moving Average of the stock is -29.10%, while the 200-Day Moving Average is calculated to be -38.44%.
Shares Statistics:
Over the past 3-months, AXGN traded about 590.22K shares per day on average, while over the past 10 days, AXGN traded about 675030 shares per day. A total of 45.51M shares are outstanding, with a floating share count of 43.02M. Insiders hold about 5.54% of the company’s shares, while institutions hold 86.27% stake in the company. Shares short for AXGN as of 1748563200 were 2049347 with a Short Ratio of 3.47, compared to 1745971200 on 1667164. Therefore, it implies a Short% of Shares Outstanding of 2049347 and a Short% of Float of 4.63.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating of Axogen Inc (AXGN) is currently shaped by the ongoing analysis conducted by 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.06, with high estimates of $0.09 and low estimates of $0.05.
Analysts are recommending an EPS of between $0.27 and $0.16 for the fiscal current year, implying an average EPS of $0.2. EPS for the following year is $0.47, with 5.0 analysts recommending between $0.73 and $0.39.
Revenue Estimates
7 analysts predict $52.61M in revenue for the current quarter. It ranges from a high estimate of $53.5M to a low estimate of $50.2M. As of the current estimate, Axogen Inc’s year-ago sales were $47.91MFor the next quarter, 7 analysts are estimating revenue of $56.16M. There is a high estimate of $56.7M for the next quarter, whereas the lowest estimate is $55.7M.
A total of 7 analysts have provided revenue estimates for AXGN’s current fiscal year. The highest revenue estimate was $217.3M, while the lowest revenue estimate was $215.5M, resulting in an average revenue estimate of $216.18M. In the same quarter a year ago, actual revenue was $187.34MBased on 7 analysts’ estimates, the company’s revenue will be $251.38M in the next fiscal year. The high estimate is $259.2M and the low estimate is $247.8M.
